# Rein Therapeutics (RNTX) — Analyst Forecast

RNTX · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/rntx/forecast

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Aug 18, 2026 | HC Wainwright & Co. | Maintained | Buy | $8.00 |
| Jul 20, 2026 | Maxim Group | Initiated Coverage | Buy | $4.00 |
| Jun 1, 2026 | HC Wainwright & Co. | Maintained | Buy | $8.00 |
| Jan 21, 2026 | Brookline Capital | Downgraded | Buy → Hold | — |
| Sep 22, 2025 | HC Wainwright & Co. | Initiated Coverage | Buy | $10.00 |
| Aug 19, 2025 | Brookline Capital | Downgraded | Buy → Hold | — |
| Apr 18, 2024 | Ladenburg Thalmann | Maintained | Buy | $19.00 |
| Dec 1, 2023 | Ladenburg Thalmann | Upgraded | Neutral → Buy | $9.00 |

## Frequently Asked Questions

### What is the latest analyst rating on RNTX?

On Aug 18, 2026, HC Wainwright & Co. maintained Rein Therapeutics at Buy with a price target of $8.00.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).